1 min read
Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...
Meet Veristat at the Orphan Drug Congress, 14-17 November 2022
Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running or just need medical writing or biostatistical support for your programs - Veristat can help. We provide impactful solutions on both a full-service or functional service basis.
Veristat team members Mariska van der Heijden, VP of European Sales and Balma Gil Gimeno, Business Development Director, will be at the venue— ready to listen to your needs and share Veristat’s expertise in orphan drug development.
If you’d like to talk to us, simply schedule a meeting by filling out the form on the right. Find out how we can help you advance your next clinical trial or regulatory submission to a successful outcome or learn more about our capabilities.
Website: https://www.terrapinn.com/conference/world-orphan-drug-congress/index.stm
1 min read
Aug 12, 2026 Veristat Blog
China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative...
1 min read
Aug 12, 2026 Veristat Blog
AI is changing clinical development, but speed alone isn't enough. In a regulated industry, every output still has to...